1.
Saffarieh E, Nassiri S, Mirmohammadkhani M. Predicting value of HE4 and CA125 markers for optimal cytoreductive surgery in ovarian cancer patients. Eur J Transl Myol [Internet]. 2022 Aug. 1 [cited 2024 Nov. 22];32(3). Available from: https://www.pagepressjournals.org/bam/article/view/10671